Mukka Proteins Ltd's Q4FY25 Quarter Results
- 16 May 2025
Result Summary
- Mukka Proteins Ltd reported a 15.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a decline of 38.2%.
- Its expenses for the quarter were down by 15.2% QoQ and 39.2% YoY.
- The net profit increased 8.8% QoQ and increased 33.0% YoY.
- The earnings per share (EPS) of Mukka Proteins Ltd stood at 1.2 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 259.97 | 308.95 | 420.53 | -15.9% | -38.2% |
Total Expenses | 234.48 | 276.51 | 385.70 | -15.2% | -39.2% |
Profit Before Tax | 25.50 | 32.45 | 34.83 | -21.4% | -26.8% |
Tax | -2.20 | 6.17 | 11.10 | -135.7% | -119.8% |
Profit After Tax | 29.15 | 26.80 | 21.92 | 8.8% | 33.0% |
Earnings Per Share | 1.20 | 0.90 | 1.00 | 33.3% | 20.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Mukka Proteins Ltd is a company that primarily operates in the protein production industry. The company's main products likely include various forms of protein, which may be used for human consumption, animal feed, or other industrial applications. The protein industry is generally characterized by its focus on nutritional and dietary supplements, animal feed, and possibly, food production. As of now, there is no additional information available regarding any recent major developments or strategic changes in the company's operations or market positioning.
Revenue
In Q4FY25, Mukka Proteins Ltd reported a total income of ₹259.97 crores, which represents a decrease of 15.9% from the previous quarter, Q3FY25, where the total income stood at ₹308.95 crores. When compared to the same quarter in the previous year, Q4FY24, the total income shows a significant decrease of 38.2%, down from ₹420.53 crores. This data indicates a substantial reduction in revenue on both a sequential and annual basis. The decrease in revenue could be attributed to various factors, including market conditions, changes in demand, or operational adjustments; however, specific causes are not detailed in the provided data.
Profitability
Mukka Proteins Ltd's profit before tax in Q4FY25 was ₹25.50 crores, reflecting a decrease of 21.4% from Q3FY25, where the profit before tax was ₹32.45 crores. The year-over-year comparison shows a decrease of 26.8% from Q4FY24, which reported a profit before tax of ₹34.83 crores. Interestingly, the company's profit after tax for Q4FY25 was ₹29.15 crores, which increased by 8.8% from Q3FY25's ₹26.80 crores and by 33.0% from Q4FY24's ₹21.92 crores. This increase in net profit despite lower pre-tax profits might be influenced by a significant reduction in taxes, which decreased by 135.7% from Q3FY25 and by 119.8% from Q4FY24, resulting in a tax benefit in Q4FY25.
Operating Metrics
The earnings per share (EPS) for Mukka Proteins Ltd in Q4FY25 was reported at ₹1.20, showing a growth of 33.3% from Q3FY25, where the EPS was ₹0.90. Compared to Q4FY24, the EPS increased by 20.0% from ₹1.00. This indicates an improvement in the earnings allocated to each share during Q4FY25. Total expenses for the quarter were ₹234.48 crores, down by 15.2% from ₹276.51 crores in Q3FY25 and by 39.2% from ₹385.70 crores in Q4FY24. The decrease in expenses is aligned with the reduction in total income, indicating potential cost management efforts or adjustments in operational activities over the periods.